Skip to main content
. 2015 Nov 4;93(5):1110–1116. doi: 10.4269/ajtmh.15-0185

Table 2.

Demographic and travel-related characteristics of immunocompromised travelers compared with immunocompetent travelers

Immunocompromised travelers Immunocompetent travelers P value*
Number (% of total) 486 (1.6) 30,702 (98.4)
Age (median, range) 46 (1.5–83) 35 (0–94) < 0.0001
Female 241 (50%) 16,672 (54%) 0.11
Destination (UNHDI classification) 0.02
 Low human development 138 (28%) 9,507 (31%)
 Medium human development 242 (50%) 14,852 (48%)
 High human development 84 (17%) 5,407 (18%)
 Very high human development 22 (5%) 936 (3%)
 Days to departure (median, range) 25 (0–424) 25 (0–564) 0.0004
 Duration of travel (days; median, range) 14 (2–700) 14 (0–9999) 0.05
Purpose of travel§
 Leisure 288 (59%) 16,563 (54%) 0.01
 Business 80 (16%) 5,711 (19%) 0.05
 VFR 62 (13%) 2,898 (9%) 0.29
 Non-medical service work 13 (3%) 2,253 (7%) 0.002
 Missionary work 20 (4%) 1,738 (6%) 0.36
 Adventuring 15 (3%) 1,678 (6%) 0.003
Accommodations§
 Camping 21 (4%) 2,213 (7%) 0.01
 Dormitory or hostel 41 (8%) 5,191 (17%) < 0.0001
 Home stay with relatives 92 (19%) 4,516 (15%) 0.07
 Hotel 353 (73%) 21,239 (69%) 0.19
 Cruise 38 (8%) 1,240 (4%) < 0.0001
Taking a medication currently 459 (94%) 17,584 (57%) < 0.0001
Number of medications per person (median, range) 3 (0–11) 1 (0–15) < 0.0001

UNHDI = United Nations Human Development Index; VFR = visiting friends and relatives.

*

P value calculated via random intercept model.

Travelers can travel to ≥ 1 destination.

All percentages are column percentages unless otherwise stated.

§

Travelers could choose more than one purpose of travel or more than one accommodation.